Treatment of colorectal cancer in Sub‐Saharan Africa: Results from a prospective Nigerian hospital registry
Autor: | Oladapo Adedayo Kolawole, Akinwumi O. Olakanmi, Adebowale I. Ajayi, Olaofe Oo, Adeleye D. Omisore, Ademola Adeyeye, Kazeem O O Ibrahim, Kenneth Seier, Aba Katung, Murray F. Brennan, Olalekan Olasehinde, Avinash Sharma, Olukayode Arowolo, Olusegun I. Alatise, Adewale O. Adisa, T. Peter Kingham, Akinwunmi O. Komolafe, A. O. Adesiyun, O C Famurewa, O. L. Idris, Ayoola D. Ibikunle, Mithat Gonen, S. O. Agodirin, Jeremy Constable, SA Olatoke, Ayoola A. Egberongbe, M. O. Adejumobi |
---|---|
Rok vydání: | 2019 |
Předmět: |
medicine.medical_specialty
business.industry Colorectal cancer medicine.medical_treatment Incidence (epidemiology) Cancer General Medicine 030230 surgery medicine.disease Chemotherapy regimen Article Radiation therapy 03 medical and health sciences 0302 clinical medicine Oncology 030220 oncology & carcinogenesis Internal medicine Medicine Surgery Lost to follow-up Stage (cooking) business Prospective cohort study |
Zdroj: | J Surg Oncol |
ISSN: | 1096-9098 0022-4790 |
DOI: | 10.1002/jso.25768 |
Popis: | BACKGROUND: Colorectal cancer (CRC) is the third most common cancer worldwide. Mortality for CRC is improving in high income countries (HIC), but in low and middle income (LMIC) countries, rates of disease and death from disease are rising. In Sub-Saharan Africa, the ratio of CRC mortality to incidence is the highest in the world. This study investigated the nature of CRC treatment currently being offered and received in Nigeria. METHODS: Between April 2013 and October 2017, a prospective study of consecutively diagnosed cases of CRC was conducted. Patient demographics, clinical features, and treatment recommended and received was recorded for each case. Patients were followed during the study period every three months or until death. RESULTS: Three hundred patients were included in our analysis. Seventy-one percent of patients received a recommended surgical operation. Of those that didn’t undergo surgery as recommended, 37% cited cost as the main reason, 30% declined due to personal reasons, and |
Databáze: | OpenAIRE |
Externí odkaz: |